BCLAF1 anticorps
Aperçu rapide pour BCLAF1 anticorps (ABIN127331)
Antigène
Voir toutes BCLAF1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- The antibody recognizes the BTF.
-
Purification
- Affinity Purified
-
Immunogène
- Synthetic peptide of human BTF
-
-
-
-
Indications d'application
-
Western Blot: 1: 500-1: 2000. Immunoprecipitation.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 30 % glycerol, 1 % BSA and 0.02 % thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- BCLAF1 (BCL2-Associated Transcription Factor 1 (BCLAF1))
-
Autre désignation
- BCLAF1 / BTF
-
Sujet
- BTF is a transcriptional repressor that interacts with several members of the BCL2 family of proteins. Overexpression of this protein induces apoptosis, which can be suppressed by co-expression of BCL2 proteins. BTF localizes to dot-like structures throughout the nucleus, and redistributes to a zone near the nuclear envelope in cells undergoing apoptosis. Multiple transcript variants encoding different isoforms have been found for this protein.Synonyms: Aa2-041, Bcl-2-associated transcription factor 1, KIAA0164
-
ID gène
- 9774
-
NCBI Accession
- NP_001070908
-
UniProt
- Q9NYF8
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Antigène
-